title: Exploring the role of anti-angiogenic therapies in prostate cancer: results from the phase 3 trial of sunitinib.
authors.affiliation: Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York, USA.
authors.forename: Himisha
authors.initials: H
authors.lastname: Beltran
authors.forename: Gurveen
authors.initials: G
authors.lastname: Kaur
authors.forename: Carmen Garcías
authors.initials: CG
authors.lastname: de España
authors.forename: Scott T
authors.initials: ST
authors.lastname: Tagawa
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D011241:Prednisone